News

Pfizer Limited informed the Bombay Stock Exchange and the National Stock Exchange of India that the trading window for dealing in shares of the company will be closed from September 30, 2026, until 48 hours after the unaudited financial results for the half year ending September 30, 2026, are made public.

Pfizer Limited announced that Mr. Sharad Goswami, Senior Director – Policy & Public Affairs, has resigned from the company effective September 25, 2026, to pursue opportunities outside Pfizer Limited, as disclosed to the Bombay Stock Exchange and the National Stock Exchange of India.

Pfizer Limited announced that it will discontinue the marketing, distribution, and sale of Minipress XL effective September 7, 2026, following a decision by Pfizer Inc. USA to discontinue the manufacture of the drug, and will receive a lump sum payment of USD 13.9 million, equivalent to Rs 131.38 crore, from Pfizer Inc. USA.

Net profit of Pfizer rose 6.63% to Rs 204.47 crore in the quarter ended June 2026 as against Rs 191.75 crore during the previous quarter ended June 2025. Sales rose 8.31% to Rs 653.17 crore in the quarter ended June 2026 as against Rs 603.05 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales653.17603.05 8 OPM %37.9034.83 - PBDT290.94273.94 6 PBT276.68259.53 7 NP204.47191.75 7 Powered by Capital Market - Live News

Pfizer will hold a meeting of the Board of Directors of the Company on 28 July 2026.